Bernat Olle

Chief Executive Officer Vedanta Biosciences

Dr. Bernat Olle is Founder and Chief Executive Officer of Vedanta Biosciences, where he has pioneered the development of defined bacterial consortia as a new class of oral therapeutics. A recognized leader in the microbiome field, he has co-authored influential research published in leading journals including Nature, JAMA, Nature Medicine, and Nature Biotechnology. Prior to Vedanta, he spent a decade in biotech venture creation at PureTech Health. Dr. Olle has served on multiple boards and advisory committees and has received numerous innovation awards. He holds a B.S., M.S., Ph.D., and M.B.A. from leading institutions including MIT and MIT Sloan.

Seminars

Wednesday 11th November 2026
Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies
9:00 am
  • Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
  • Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
  • Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand
Bernat Olle, Vedanta Bio - Expert Speaker at the 11th Microbiome Movement USA Summit